PUBLISHER: IMARC | PRODUCT CODE: 1521231
PUBLISHER: IMARC | PRODUCT CODE: 1521231
The global vessel sealing devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.
Vessel sealing devices refer to instruments used in non-invasive surgical procedures to facilitate dissection and hemostasis during open and laparoscopic procedures. Electrothermal bipolar vessel sealers and ultrasonic shears are some of the commonly used vessel sealing devices. They consist of ultrasonic, bipolar and hybrid energies and are helpful in coagulation, cutting and dissection applications. Vessel sealing devices are widely used to seal the vessel wall by denaturing the collagen and elastin in the wall and completely occluding the blood vessel. These devices are easy to use, require less operational time, assist in reducing blood loss, offer superior efficiency and reliability, and are cost-effective. As a result, vessel sealing devices are widely used in specialty clinics, hospitals and ambulatory surgical centers.
The increasing geriatric population that is more prone to chronic diseases is one of the key factors creating a positive outlook for the market. Vessel sealing devices are widely used to treat colorectal cancer, neck surgery, axillary dissection, and chronic hepatitis, amongst others. Additionally, the widespread product adoption in laparoscopic surgeries as they are minimally invasive and cause less postoperative pain, is favoring the market growth. Apart from this, the introduction of ultrasound technology that monitors the distribution of heat and energy and bipolar devices that assist in stronger and uniform compression, are also providing a thrust to the market growth. Moreover, the increasing demand for safe and effective instruments during surgeries to reduce infection rates and blood loss is inflating the overall sales of medical sealing devices, thus positively impacting the market growth. Other factors, including the development of novel, high-quality vessel sealing devices, a rise in the number of gynecological, urological, cardiovascular and orthopedic surgeries, and significant expansion in the medical industry, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vessel sealing devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Generators
Instruments
Accessories
General Surgery
Laparoscopic Surgery
Hospitals and Specialty Clinics
Ambulatory Surgical Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, BOWA-electronic GmbH & Co. KG, Erbe Elektromedizin GmbH, Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, KLS Martin Group, Lamidey Noury Medical, Medtronic plc, Olympus Corporation, OmniGuide Holdings Inc. and Xcellance Medical Technologies Private Limited.